Rafferty Asset Management LLC raised its stake in Humana Inc. (NYSE:HUM - Free Report) by 11.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,659 shares of the insurance provider's stock after acquiring an additional 1,448 shares during the period. Rafferty Asset Management LLC's holdings in Humana were worth $3,465,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. bought a new stake in shares of Humana during the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new position in Humana during the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA lifted its stake in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new stake in Humana during the fourth quarter worth $33,000. Finally, Transce3nd LLC acquired a new stake in shares of Humana in the 4th quarter valued at $38,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on HUM. Oppenheimer raised their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Robert W. Baird boosted their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Mizuho upped their price target on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Barclays raised their price objective on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Humana has an average rating of "Hold" and an average target price of $286.81.
Get Our Latest Analysis on HUM
Humana Price Performance
Shares of HUM traded down $19.60 during trading hours on Thursday, reaching $226.17. 3,003,913 shares of the stock traded hands, compared to its average volume of 1,777,742. Humana Inc. has a 52-week low of $212.45 and a 52-week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $27.30 billion, a P/E ratio of 22.73, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company's 50-day moving average price is $262.84 and its two-hundred day moving average price is $269.22.
Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. Humana's quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the company posted $7.23 earnings per share. On average, analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.57%. Humana's dividend payout ratio (DPR) is presently 25.04%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Read More

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.